Categories List
Payment Methods
Shipping Option
Shopping cart
People who bought this, also bought:
Lamotrigine belongs to the group of anticonvulsant drugs. This medication is used to treat epilepsy and bipolar disorder. Lamotrigine can be also applied for other purposes.
$0.83
Buy now
Topiramate is used to treat convulsions, epilepsy in children and adults, and also to prevent migraines and certain psychiatric conditions.
$0.66
Buy now
Oxytrol treats symptoms of overactive bladder via reduction of muscle spasms of the bladder and urinary tract.
$0.92
Buy now
Strattera is prescribed to treat attention deficit hyperactivity disorder
$0.67
Buy now
Synthroid contains substance identical to the thyroid gland hormone and is used to treat hypothyroidism and obesity.
$0.36
Buy now
Testimonials
Barbara Smith, Ansonia, United States
I AM SO SORRY TO HAVE DOUBTED YOUR SERVICE. I RECEIVED A NOTICE FROM THE POST OFFICE ON FRIDAY 11/4, THAT A REG. MAIL FROM YOU WAS THERE. I WILL BE RECEIVING THE PACKAGE TODAY. THANK YOU SO MUCH FOR ALL ... Elliot, 53, Tennessee
“I just turned 53 young, not so old, huh, and have been suffering from erectile dysfunction for more than 8 years. Different techniques and medications did not help me or were useful just for a while and ...
Social bookmarks
News
Massive hope for pancreatic cancer pill after trial saw tumours vanish
Daily pill daraxonrasib appears to shrink and possibly even eliminate tumours in some patients with one of the deadliest cancers. Covid inquiry report: key findings on testing, tracing and 'the pingdemic'
Early efforts to contain coronavirus "were doomed to fail", the public inquiry has found. Here's what you need to know. Regulator mistakenly sent complaints about doctors to newspaper
Information sent to the Times newspaper by the General Medical Council included summaries of complaints alleging antisemitism and Islamophobia against ... Voy at-home test kit adverts banned over low testosterone claims
The Advertising Standards Authority says the adverts by online healthcare provider Voy made misleading claims.